Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...

China: A recent study highlights the potential of ultrasonic viscoelastic imaging as a noninvasive tool for evaluating ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients ...

The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

Now, a new study suggests that vivid hallucinations—both during sleep and while awake—could point to an underlying autoimmune disorder. Published in the journal eClinicalMedicine, a recent study found ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...

Kris Aquino revealed her “pain and struggle” amid suffering from lupus flare fever for over two weeks now, appealing to the ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...